Sonnenblick Amir

anos de experiência

4.5

Avaliação

Sonnenblick Amir

Especialização: Clinical oncologist
18 anos de experiência
Fala:
English, Hebrew
Local de trabalho: Israel, Telavive, Sourasky Medical Center (Ichilov)
Dr. Sonnenblick Amir is a renowned surgical oncologist with a specialized focus in breast cancer. He has received several accolades for his work, including the ESMO Breast Cancer Translational Research Award and ISCORT Best Paper of the Year Award twice. He is known for his involvement in important clinical trials such as 'Aphinity' and 'Olympia'. He has also contributed to over 30 national and international scientific meetings and his research has been published on numerous occasions.

Avaliações de pacientes

4.5

Pontuação boa

153 avaliações de pacientes verificadas

1 estrelas

10%

2 estrelas

3 estrelas

10%

4 estrelas

5 estrelas

80%

Detalhamento da avaliação

Médico

4.7/5

Equipe

4.5/5

Instalações

4.5/5

Assistência linguística

4.6/5

Suporte

4.8/5

Sua confiança é nossa principal prioridade

Valorizamos sua confiança acima de tudo, portanto as clínicas não podem pagar para alterar ou remover avaliações.

Saiba mais sobre as avaliações.

Evgeny • Check-up Masculino

Ucrânia

27 de fev. de 2025

Avaliação verificada.

Tomiris • Consulta nefrologista

Cazaquistão

22 de ago. de 2025

Avaliação verificada.

I liked the doctor's counselling

Stanislav • Cancro do estômago

Bielorrússia

31 de jan. de 2024

Avaliação verificada.

We are very grateful for the small chance that these doctors gave us

Вячеслав • Check-up Masculino

Sri Lanca

2 de fev. de 2023

Avaliação verificada.

Service at the highest level

Anônimo • VIH

Federação Russa

8 de mai. de 2019

Avaliação verificada.

Carregar mais

Serviços do médico

Ver mais

Como estamos indo?

1 de 3

As informações sobre este médico estão completas e claras

Discordo totalmente

Concordo totalmente

Qualificações

Dr. Amir specializes in various therapies for breast cancer, including chemotherapy, radiotherapy, hormone therapy, and targeted therapy with Keytruda (Pembolizumab). His academic contributions include over 30 presentations at national and international scientific meetings.

Awards

2004: Wolf Award for PhD students
2006: Foulkes Award for MD/PhD students
2013: ESMO Breast Cancer Translational Research Award
2016: ISCORT Best Paper of the Year Award
2017: ISCORT Best Paper of the Year Award

Membership

Israeli Medical Association
Israeli Society of Clinical Oncology
Israeli Society for Cancer Research (ISCR)
European Association of Cancer Research (EACR)
European Society of Medical Oncology (ESMO)

Education

1998-2007: The Hebrew University, Jerusalem, Israel (MD/PhD track)
2013-2015: ESMO Breast Cancer Translational and Clinical Research Fellowship, Jules Bordet Institute, Brussels
2012: Fellowship in Breast Cancer Research, International Program at Emory University, Atlanta, GA, USA